The Black Technology Era of Xueba

Genius to remember the address of this site in one second: []The fastest update! No ads!

Several factories in Jiangcheng, Shanghai and Suzhou and Hangzhou were acquired by Pangu Technology half a year ago, and currently belong to the Pangu Technology Group Shoreline Company.

After transformation and equipment replacement, it has the ability to experiment and produce as before.

During this period, the Affiliated Hospital of Jiangda University has performed several reconstructive surgeries, and drugs such as gene induction and self-induction were produced from factories in Suzhou and Hangzhou.

Several factories in Jiangcheng and Shanghai have also been renovated, and will become the living warehouses of human medicine in the future.

Life Warehouse, the name is tall, and to put it more directly, it is actually a place that specializes in training and producing medical transplants.

There is no one other than the coastline company, a subsidiary of Pangu Technology, that can mass-produce the qiguan required for human medical transplantation.

As Gao Siqi's proud younger brother and the core figure of Pangu Technology's life science laboratory, Shao Yiping was appointed as the executive general manager of Shoreline Company. The first thing he did when he took office was to ensure production.

However, what Shao Yiping needs at present is to wait, wait for the implementation of relevant policies, and wait for the headquarters to speak.

Jiangcheng Industrial Zone, in the workshop of Shoreline Medical Company.

Shao Yiping looked at the busy workers and knew very well that this was his stage.

The application report was quickly responded by relevant departments and industry associations.

On the premise of treating patients, it can be piloted in Yanjing, Jiangcheng, Shanghai, Suzhou and Hangzhou, Rongcheng, Shenzhen and Yangcheng. The cost is set by Pangu Technology. And it must be registered and filed, and it is also necessary for Pan Technology to come up with a specific plan.

It was originally a trial, and both the cost and the needs of patients need to be balanced in constant exploration, so it is the best way to leave everything to the market in terms of price.

After a period of trial, the relevant departments will seek the opinions of Pangu Technology, and finally decide the relevant price, so that the price and profit are open and transparent.

Since the trial is allowed, it will be easy to handle.

After receiving the official notice from Gao Siqi, Shao Yiping said confidently: "The future era of treatment belonging to Pangu Technology has come."

Xiao Ming also called Shao Yiping and asked him to confirm the situation of the equipment and personnel again, because some of them were busy next time.

Gao Siqi said, "Are you sure that patients and hospitals can immediately accept large-scale and mass-produced production?"

Xiao Ming is of course very sure, "This is a brand new market, and it is also a market that is urgently needed in the medical field. Many patients and doctors are waiting for this day."

Shao Yiping quickly formulated a detailed plan.

The patient needs to purchase the qiguan organization cultivated by the coastline company. The process is as follows.

1. The condition of the patient diagnosed in the hospital needs to be transplanted to save his life or the condition has improved significantly;

2. The patient submits an application to the hospital for purchasing a medical device, and the hospital and the patient report to the higher authorities after signing an agreement;

3. The competent department organizes experts to demonstrate the patient's condition, and issue a consent letter after confirmation;

(The above three steps must be completed within three days.)

4. Pangu Technology cooperates with the patient’s hospital to collect patient-related tissue and gene samples (at this time, the hospital will pay Pangu Technology for the completion of the training fee);

5. Pangu Technology trains Qi officials and transfers them to the hospital after successful training (one week to half a month);

6. The hospital will carry out the transplant operation after accepting the qiguan.

Before the trial, life science laboratories also conducted extensive evaluations and set prices accordingly.

Among them, liver source 300,000 soft sister coins; kidney source 150,000 soft sister coins; heart 300,000 soft sister coins; cornea 150,000 pairs; pancreas 200,000 soft sister coins; small intestine 200,000 soft sister coins; ziGong 300,000 soft sister coins , and the rest include skin, fingers, and other tissues or organs that can be transplanted.

Although most of the prices are above 100,000 soft sister coins, they are much cheaper than the market price.

Moreover, Shoreline can guarantee absolute stock, absolute health, and absolutely no rejection.

When Shao Yiping sent Qi Guan's price list to Xiao Ming's office, Gao Siqi on the side had an illusion.

"What? Do you have any better suggestions?" Xiao Ming asked.

Gao Siqi covered her head and said, "No, why do I think we are a bit like a butcher in a vegetable market selling offal... a little awkward."

It must be a little awkward. Looking at the world, Pangu Technology is the only one that can cultivate human officials into a large-scale industry.

Xiao Ming said with a smile: "Let's put your mind at ease, we are rigorous medicine."

Afterwards, Xiao Ming called Lin Li, the executive chairman, "Shoreline Company's proposal price application form has been submitted, please take a look."

Pangu Technology Group is involved in more and more fields. Xiao Ming still tries not to interfere with the company's routine affairs as he just founded the company. Therefore, according to the company's rules, the application form needs to be signed by this year's executive chairman Lin Li.

Lin Li is an old man in Xiao Ming's hands. He understands what the boss means. Since the boss has seen it, he will definitely not object.

After a brief review, Lin Li reported the plan to the relevant departments.

After the plan and price are determined, the official sales of the coastline company are officially completed, and they will be implemented after waiting for approval.

...

Rongcheng, Shanchuan Provincial People's Hospital.

Cardiology meeting room.

Experts are consulting a critically ill patient.

The 12-day-old baby Yunyun is still in the incubator. Yunyun suffers from four serious heart diseases. Ordinary heart repair surgery can no longer save this poor child. The diseased heart disease can take the child's life at any time. .

The attending physician, Professor Chen, the doctoral supervisor of basic and clinical structural heart disease at Shanchuan University, reviewed the patient's medical records in detail.

Finally, put forward your own opinion: "change your heart."

A 12-day-old baby has a heart transplant operation. Not to mention the difficulty of the operation, it is also a big problem when to find a suitable heart source.

Professor Ma said: "At present, it seems that it is only feasible to replace a new heart for Yunyun. This is the source of the heart is a big problem."

Xia Guozheng's hearts were basically donations, so the number of donations to Yunyun was very small, and they needed to be paired successfully, so the chance was even smaller.

Since Shoreline's qi officer training plan is still waiting for approval, the experts and professors working on the front line of medicine have really not thought of this.

After telling Yunyun's mother Yin Fei the results of the diagnosis, Yin Fei and her husband Li Jun hugged each other and cried.

The consultation has a treatment method, but where can I find the source of the heart in a short period of time?

Professor Liu said: "We have contacted relevant institutions to find out, and hope to have good results."

Half a day later, after a nationwide online inquiry.

The number of hearts currently applicable to Yunyun is -0.